Infimer Stock Market Capitalization
| INFR-M Stock | 14.60 14.50 14,500% |
Infimer fundamentals help investors to digest information that contributes to Infimer's financial success or failures. It also enables traders to predict the movement of Infimer Stock. The fundamental analysis module provides a way to measure Infimer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Infimer stock.
Infimer |
Infimer Company Market Capitalization Analysis
Infimer's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of Infimer is about 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Market Capitalization (which currently averages 0.0) industry. This indicator is about the same for all Israel stocks average (which is currently at 0.0).
Infimer Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Infimer's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Infimer could also be used in its relative valuation, which is a method of valuing Infimer by comparing valuation metrics of similar companies.Infimer is currently under evaluation in market capitalization category among its peers.
Infimer Fundamentals
| Return On Asset | 0.49 | |||
| Shares Owned By Insiders | 6.64 % | |||
| Shares Owned By Institutions | 10.03 % | |||
| Revenue | 350 K | |||
| Gross Profit | (401 K) | |||
| EBITDA | 1.5 M | |||
| Book Value Per Share | (4.63) X | |||
| Earnings Per Share | (0.59) X | |||
| Beta | 1.62 |
About Infimer Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Infimer's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Infimer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Infimer based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Infimer Stock
Infimer financial ratios help investors to determine whether Infimer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Infimer with respect to the benefits of owning Infimer security.